期刊文献+

深低温停循环间断灌注脑保护液的实验研究 被引量:1

Experimental study of cerebral protection of intermittent cerebroplegia perfusion during deep hypothermic circulatory arrest
原文传递
导出
摘要 目的 研究深低温停循环 (DHCA)间断灌注充氧脑保护液的脑保护效果及机制。方法健康杂种犬 10条 ,A组单纯DHCA 12 0min ,B组DHCA后经双侧颈动脉间断灌注充氧脑保护液。两组动物于不同时相取皮层组织测定其三磷酸腺苷 (ATP)的含量及一氧化氮合酶 (NOS)的活性 ,并作透射电镜 (TE)检查。结果 DHCA 12 0min及恢复循环 45min后 ,B组皮层组织ATP的含量均明显高于A组。A组皮层组织还原型尼克酰胺二磷酸腺苷脱氢酶 (NADPH)阳性神经细胞数量明显多于B组。TE检查显示A组皮层组织线粒体结构破坏严重而B组改变轻微。结论 DHCA间断灌注充氧脑保护液是一种较为理想的脑保护方法。 Objective\ To study the protective effect and the protective mechanism of intermittent oxygenated cerebroplegia perfusion during deep hypothermic circulatory arrest (DHCA). Methods\ Ten mongrel dogs underwent DHCA for 120 min. Five dogs in group B received oxygenated cerebroplegic infusion and 5 dogs in group A did not following DHCA. Cerebral cortex was collected at different time points to determine ATP content, NOS activity and examine the ultrastructure under transmission electron microscopy. Results\ At 120 min of DHCA and at 45 min of reperfusion, the content of ATP in the group B was higher significantly than in the group A. The number of NOS positive neurons in the group A was higher significantly than in the group B. TE examination revealed that the damage of the ultrastructure in the group A was more severe than in the group B. Conclusion\ Intermittent oxygenated cerebroplegia perfusion during DHCA is an optimal cerebral protective method.\;
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2000年第6期501-502,共2页 Chinese Journal of Experimental Surgery
关键词 脑保护液 体外循环 深低温停循环 间断灌注 充氧 Assisted cirulation \ Cerebroplegia \ Nitric oxide
  • 相关文献

参考文献1

二级参考文献2

  • 1周源,中华麻醉学杂志,1987年,7卷,193页
  • 2马述仕,中华医学杂志,1986年,66卷,544页

共引文献1

同被引文献9

  • 1徐志云,王为,黄盛东,李凯.深低温停循环经右锁骨下动脉持续脑灌注与经上腔静脉逆行脑灌注的比较[J].中华实验外科杂志,2005,22(5):574-576. 被引量:5
  • 2Brazil D,Yang Z,Hemmings B.Advances in protein kinase B signalling:Aktion on multiple fronts.Trends Biochem Sci,2004,29:233-242.
  • 3Yang ZZ,Tschopp O,Baudry A,et al.B.A.Physiological functions of protein kinase B/Akt.Biochem Soc Trans,2004,32:350-354.
  • 4Song G,Ouyang G,Bao S,et al.The activation of AKT/PKB signaling pathway and cell survival.J Cell Mol Med,2005,9:59-71.
  • 5Nogueira V,Park Y,Chen CC,et al.AKT determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis.Cancer Cell,2008,14:458-470.
  • 6He X,Mo X,Gu H,et al.Neuroprotective effect of diazoxide on brain injury induced by cerebral ischemia/reperfusion during deep hypothermia.J Neurological Sciences,2008,268:18-27.
  • 7Woodgett J.Recent advances in the protein kinase B signaling pathway.Curr Opin Cell Biol,2005,17:150-157.
  • 8Dummler B,Hemmings B.Physiological roles of PKB/Akt isoforms in development and disease.Biochem Soc Trans,2007,35:231-235.
  • 9Pugazhenthi S,Nesterova A,Sable C,et al.Akt/Protein Kinase B up-regulates bcl-2 expression cAMP-response element-binding protein.J Biol Chem,2000,275:10761-10766.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部